Business Wire

Global Water and Wastewater Utilities Take Aim at Climate Change

18.5.2023 16:00:00 EEST | Business Wire | Press release

Share

Water and wastewater utilities are executing ambitious decarbonization goals, according to a new survey of 100 utilities in North America and Europe. Sponsored by global water technology leader Xylem (NYSE: XYL), the survey finds that 75% of respondents intend to achieve greenhouse gas (GHG) reduction goals by 2040 or earlier. 48% of respondents have set a net-zero emissions goal, and 42% have set an emissions reduction goal.

“The water sector has an important role in the global effort to reduce GHG emissions,” said Patrick Decker, President and CEO at Xylem. “Our sector is energy intensive. However, smart application of technology makes it possible to manage water far more efficiently and affordably. Increasingly, utilities are finding ways to deploy technology to become more resilient and reduce emissions, while also addressing many of their operational concerns.”

The implementation of new and innovative products and solutions can help utilities advance their decarbonization strategies. As highlighted in its recently launched 2022 Sustainability Report, Xylem’s cutting-edge technologies have enabled customers to reduce their CO2e footprint by more than 2.8 million metric tons since 2019. Around the world, leading water and wastewater utilities are focusing on such solutions to drive GHG reduction plans.

In Europe, for example, 31% of respondents plan on installing more energy-efficient technologies. Others are leveraging digital solutions, with 29% looking into advanced metering infrastructure (AMI) and leak detection solutions, and 24% turning to treatment system optimization technologies. Similarly in North America, 35% of respondents plan on implementing plant or asset optimization technologies to advance their decarbonization goals.

With 37% of North American respondents citing resilience to extreme storms and floods as a major concern, advanced digital solutions are also helping water managers improve operational and environmental outcomes at an affordable cost. Buffalo Sewer Authority (BSA), U.S., for example, saved $145 million by deploying a smart sewer system that reduced polluted water flowing into its rivers during storm events – ultimately solving a longstanding problem without spending on new infrastructure.

“To bridge resource gaps and serve our communities as efficiently as possible, we need to work smarter,” Oluwole A. (OJ) McFoy, BSA General Manager, said. “We have shown this technology is effective and can help ensure that Buffalo is more efficient and prepared for the changing climate and the more intense storms coming our way.”

Many utilities ranked process emissions – such as methane and nitrous oxide – close to last in their priorities for action, despite their significant impact, showing that a better understanding of this issue and technological innovation are needed to tackle total water-sector emissions.

The decarbonization strategies being deployed by these forward-thinking utilities are captured in Xylem’s recent paper, Net Zero – The Race We All Win.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our more than 17,000 diverse employees delivered revenue of $5.5 billion in 2022. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Houston Spencer
+1 (914) 240-3046
Houston.Spencer@xylem.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f

Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye